{"transactions":[{"id":2658202,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":137986,"kind":"organization","name":"DCVC Bio, L.P.","position":1,"cik":"0001735069","reported_name":"DCVC Bio, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119945,"kind":"organization","name":"DCVC Bio GP, LLC","position":2,"cik":"0001735070","reported_name":"DCVC Bio GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137987,"kind":"organization","name":"JNK Capital Management, LLC","position":3,"cik":"0001836273","reported_name":"JNK Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137988,"kind":"organization","name":"ZNM Capital Management, LLC","position":4,"cik":"0001836103","reported_name":"ZNM Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111559,"kind":"person","name":"Bogue Zachary","position":5,"cik":"0001836157","reported_name":"Bogue Zachary","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75187,"kind":"person","name":"Ocko Matthew","position":6,"cik":"0001836089","reported_name":"Ocko Matthew","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137989,"kind":"person","name":"Stead Kiersten","position":7,"cik":"0001836117","reported_name":"Stead Kiersten","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-06-22T22:13:35.000Z","date":"2021-06-18","kind":"other","acquired":true,"shares":73892,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 18, 2021, DCVC Bio, L.P. (\"DCVC Bio\") distributed, for no consideration, an aggregate of 5,000,000 Common Shares of the Issuer (\"DCVC Bio Shares\") to its limited partners and to DCVC Bio GP, LLC (\"DCVC Bio GP\"), its general partner, representing each such partner's pro rata interest in such DCVC Bio Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 18, 2021, DCVC Bio, L.P. (\"DCVC Bio\") distributed, for no consideration, an aggregate of 5,000,000 Common Shares of the Issuer (\"DCVC Bio Shares\") to its limited partners and to DCVC Bio GP, LLC (\"DCVC Bio GP\"), its general partner, representing each such partner's pro rata interest in such DCVC Bio Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are held by DCVC Bio GP.  JNK and ZNM are the managing members of DCVC Bio GP and share voting and dispositive power with respect to the securities held by DCVC Bio GP. The managing members of JNK and ZNM are Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead. Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead share voting and dispositive power with respect to the securities held by DCVC Bio GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"(Continued from Footnote 4) Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of such securities and this report shall not be deemed an admission that it is the beneficial owner of such securities, except to the extent of its indirect pecuniary interest therein, if any."}],"balance_after":73892,"source":{"system":"sec-edgar","filing":"0001209191-21-042496","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919121042496/doc4.xml","form_type":"4"}},{"id":2658201,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":137986,"kind":"organization","name":"DCVC Bio, L.P.","position":1,"cik":"0001735069","reported_name":"DCVC Bio, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119945,"kind":"organization","name":"DCVC Bio GP, LLC","position":2,"cik":"0001735070","reported_name":"DCVC Bio GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137987,"kind":"organization","name":"JNK Capital Management, LLC","position":3,"cik":"0001836273","reported_name":"JNK Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137988,"kind":"organization","name":"ZNM Capital Management, LLC","position":4,"cik":"0001836103","reported_name":"ZNM Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111559,"kind":"person","name":"Bogue Zachary","position":5,"cik":"0001836157","reported_name":"Bogue Zachary","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75187,"kind":"person","name":"Ocko Matthew","position":6,"cik":"0001836089","reported_name":"Ocko Matthew","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137989,"kind":"person","name":"Stead Kiersten","position":7,"cik":"0001836117","reported_name":"Stead Kiersten","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2021-06-22T22:13:35.000Z","date":"2021-06-18","kind":"other","acquired":false,"shares":5000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 18, 2021, DCVC Bio, L.P. (\"DCVC Bio\") distributed, for no consideration, an aggregate of 5,000,000 Common Shares of the Issuer (\"DCVC Bio Shares\") to its limited partners and to DCVC Bio GP, LLC (\"DCVC Bio GP\"), its general partner, representing each such partner's pro rata interest in such DCVC Bio Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 18, 2021, DCVC Bio, L.P. (\"DCVC Bio\") distributed, for no consideration, an aggregate of 5,000,000 Common Shares of the Issuer (\"DCVC Bio Shares\") to its limited partners and to DCVC Bio GP, LLC (\"DCVC Bio GP\"), its general partner, representing each such partner's pro rata interest in such DCVC Bio Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held by DCVC Bio. DCVC Bio GP is the general partner of DCVC Bio and has sole voting and dispositive power with regard to the securities held by DCVC Bio. JNK Capital Management, LLC (\"JNK\") and ZNM Capital Management, LLC (\"ZNM\") are the managing members of DCVC Bio GP and share voting and dispositive power with respect to the securities held by DCVC Bio. The managing members of JNK and ZNM are Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead. Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead share voting and dispositive power with respect to the securities held by DCVC Bio."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(Continued from Footnote 2) Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of such securities and this report shall not be deemed an admission that it is the beneficial owner of such securities, except to the extent of its indirect pecuniary interest therein, if any."}],"balance_after":24105761,"source":{"system":"sec-edgar","filing":"0001209191-21-042496","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919121042496/doc4.xml","form_type":"4"}},{"id":2939104,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":137986,"kind":"organization","name":"DCVC Bio, L.P.","position":1,"cik":"0001735069","reported_name":"DCVC Bio, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111559,"kind":"person","name":"Bogue Zachary","position":2,"cik":"0001836157","reported_name":"Bogue Zachary","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119945,"kind":"organization","name":"DCVC Bio GP, LLC","position":3,"cik":"0001735070","reported_name":"DCVC Bio GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137987,"kind":"organization","name":"JNK Capital Management, LLC","position":4,"cik":"0001836273","reported_name":"JNK Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75187,"kind":"person","name":"Ocko Matthew","position":5,"cik":"0001836089","reported_name":"Ocko Matthew","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137989,"kind":"person","name":"Stead Kiersten","position":6,"cik":"0001836117","reported_name":"Stead Kiersten","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137988,"kind":"organization","name":"ZNM Capital Management, LLC","position":7,"cik":"0001836103","reported_name":"ZNM Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Note","published_at":"2020-12-18T01:45:44.000Z","date":"2020-12-15","kind":"exercise","acquired":false,"price":0,"reported_value":500000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The convertible promissory note (\"Convertible Note\") had a maturity date of October 30, 2025 and the principal amount of the Convertible Note converted upon the closing of the IPO into Common Shares at a conversion price equal to $17.00 per Common Share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The convertible promissory note (\"Convertible Note\") had a maturity date of October 30, 2025 and the principal amount of the Convertible Note converted upon the closing of the IPO into Common Shares at a conversion price equal to $17.00 per Common Share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held by DCVC Bio, L.P. (\"DCVC Bio\"). DCVC Bio GP, LLC (\"DCVC Bio GP\") is the general partner of DCVC Bio and has sole voting and dispositive power with regard to the securities held by DCVC Bio. JNK Capital Management, LLC (\"JNK\") and ZNM Capital Management, LLC (\"ZNM\") are the managing members of DCVC Bio GP and share voting and dispositive power with respect to the securities held by DCVC Bio. The managing members of JNK and ZNM are Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead. Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead share voting and dispositive power with respect to the securities held by DCVC Bio."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(Continued from Footnote 2) Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of such securities and this report shall not be deemed an admission that it is the beneficial owner of such securities, except to the extent of its indirect pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"exercise_price":17,"underlying":"Common Shares","underlying_shares":29411},"source":{"system":"sec-edgar","filing":"0001209191-20-064259","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919120064259/doc4.xml","form_type":"4"}},{"id":2939103,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":137986,"kind":"organization","name":"DCVC Bio, L.P.","position":1,"cik":"0001735069","reported_name":"DCVC Bio, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111559,"kind":"person","name":"Bogue Zachary","position":2,"cik":"0001836157","reported_name":"Bogue Zachary","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119945,"kind":"organization","name":"DCVC Bio GP, LLC","position":3,"cik":"0001735070","reported_name":"DCVC Bio GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137987,"kind":"organization","name":"JNK Capital Management, LLC","position":4,"cik":"0001836273","reported_name":"JNK Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75187,"kind":"person","name":"Ocko Matthew","position":5,"cik":"0001836089","reported_name":"Ocko Matthew","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137989,"kind":"person","name":"Stead Kiersten","position":6,"cik":"0001836117","reported_name":"Stead Kiersten","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137988,"kind":"organization","name":"ZNM Capital Management, LLC","position":7,"cik":"0001836103","reported_name":"ZNM Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A2 Preferred Shares","published_at":"2020-12-18T01:45:44.000Z","date":"2020-12-15","kind":"exercise","acquired":false,"shares":802371,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A1 Preferred Shares and Series A2 Preferred Shares (collectively, the \"Preferred Shares\") were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering (\"IPO\"). The Preferred Shares converted into Common Shares at a 1:10 ratio upon the closing of the IPO without payment of additional consideration. The Preferred Shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A1 Preferred Shares and Series A2 Preferred Shares (collectively, the \"Preferred Shares\") were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering (\"IPO\"). The Preferred Shares converted into Common Shares at a 1:10 ratio upon the closing of the IPO without payment of additional consideration. The Preferred Shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A1 Preferred Shares and Series A2 Preferred Shares (collectively, the \"Preferred Shares\") were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering (\"IPO\"). The Preferred Shares converted into Common Shares at a 1:10 ratio upon the closing of the IPO without payment of additional consideration. The Preferred Shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held by DCVC Bio, L.P. (\"DCVC Bio\"). DCVC Bio GP, LLC (\"DCVC Bio GP\") is the general partner of DCVC Bio and has sole voting and dispositive power with regard to the securities held by DCVC Bio. JNK Capital Management, LLC (\"JNK\") and ZNM Capital Management, LLC (\"ZNM\") are the managing members of DCVC Bio GP and share voting and dispositive power with respect to the securities held by DCVC Bio. The managing members of JNK and ZNM are Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead. Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead share voting and dispositive power with respect to the securities held by DCVC Bio."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(Continued from Footnote 2) Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of such securities and this report shall not be deemed an admission that it is the beneficial owner of such securities, except to the extent of its indirect pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":8023710},"source":{"system":"sec-edgar","filing":"0001209191-20-064259","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919120064259/doc4.xml","form_type":"4"}},{"id":2939102,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":137986,"kind":"organization","name":"DCVC Bio, L.P.","position":1,"cik":"0001735069","reported_name":"DCVC Bio, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111559,"kind":"person","name":"Bogue Zachary","position":2,"cik":"0001836157","reported_name":"Bogue Zachary","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119945,"kind":"organization","name":"DCVC Bio GP, LLC","position":3,"cik":"0001735070","reported_name":"DCVC Bio GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137987,"kind":"organization","name":"JNK Capital Management, LLC","position":4,"cik":"0001836273","reported_name":"JNK Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75187,"kind":"person","name":"Ocko Matthew","position":5,"cik":"0001836089","reported_name":"Ocko Matthew","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137989,"kind":"person","name":"Stead Kiersten","position":6,"cik":"0001836117","reported_name":"Stead Kiersten","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137988,"kind":"organization","name":"ZNM Capital Management, LLC","position":7,"cik":"0001836103","reported_name":"ZNM Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A1 Preferred Shares","published_at":"2020-12-18T01:45:44.000Z","date":"2020-12-15","kind":"exercise","acquired":false,"shares":2105264,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A1 Preferred Shares and Series A2 Preferred Shares (collectively, the \"Preferred Shares\") were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering (\"IPO\"). The Preferred Shares converted into Common Shares at a 1:10 ratio upon the closing of the IPO without payment of additional consideration. The Preferred Shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A1 Preferred Shares and Series A2 Preferred Shares (collectively, the \"Preferred Shares\") were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering (\"IPO\"). The Preferred Shares converted into Common Shares at a 1:10 ratio upon the closing of the IPO without payment of additional consideration. The Preferred Shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A1 Preferred Shares and Series A2 Preferred Shares (collectively, the \"Preferred Shares\") were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering (\"IPO\"). The Preferred Shares converted into Common Shares at a 1:10 ratio upon the closing of the IPO without payment of additional consideration. The Preferred Shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held by DCVC Bio, L.P. (\"DCVC Bio\"). DCVC Bio GP, LLC (\"DCVC Bio GP\") is the general partner of DCVC Bio and has sole voting and dispositive power with regard to the securities held by DCVC Bio. JNK Capital Management, LLC (\"JNK\") and ZNM Capital Management, LLC (\"ZNM\") are the managing members of DCVC Bio GP and share voting and dispositive power with respect to the securities held by DCVC Bio. The managing members of JNK and ZNM are Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead. Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead share voting and dispositive power with respect to the securities held by DCVC Bio."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(Continued from Footnote 2) Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of such securities and this report shall not be deemed an admission that it is the beneficial owner of such securities, except to the extent of its indirect pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":21052640},"source":{"system":"sec-edgar","filing":"0001209191-20-064259","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919120064259/doc4.xml","form_type":"4"}},{"id":2939101,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":137986,"kind":"organization","name":"DCVC Bio, L.P.","position":1,"cik":"0001735069","reported_name":"DCVC Bio, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111559,"kind":"person","name":"Bogue Zachary","position":2,"cik":"0001836157","reported_name":"Bogue Zachary","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119945,"kind":"organization","name":"DCVC Bio GP, LLC","position":3,"cik":"0001735070","reported_name":"DCVC Bio GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137987,"kind":"organization","name":"JNK Capital Management, LLC","position":4,"cik":"0001836273","reported_name":"JNK Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75187,"kind":"person","name":"Ocko Matthew","position":5,"cik":"0001836089","reported_name":"Ocko Matthew","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137989,"kind":"person","name":"Stead Kiersten","position":6,"cik":"0001836117","reported_name":"Stead Kiersten","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137988,"kind":"organization","name":"ZNM Capital Management, LLC","position":7,"cik":"0001836103","reported_name":"ZNM Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2020-12-18T01:45:44.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":29411,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The convertible promissory note (\"Convertible Note\") had a maturity date of October 30, 2025 and the principal amount of the Convertible Note converted upon the closing of the IPO into Common Shares at a conversion price equal to $17.00 per Common Share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held by DCVC Bio, L.P. (\"DCVC Bio\"). DCVC Bio GP, LLC (\"DCVC Bio GP\") is the general partner of DCVC Bio and has sole voting and dispositive power with regard to the securities held by DCVC Bio. JNK Capital Management, LLC (\"JNK\") and ZNM Capital Management, LLC (\"ZNM\") are the managing members of DCVC Bio GP and share voting and dispositive power with respect to the securities held by DCVC Bio. The managing members of JNK and ZNM are Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead. Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead share voting and dispositive power with respect to the securities held by DCVC Bio."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(Continued from Footnote 2) Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of such securities and this report shall not be deemed an admission that it is the beneficial owner of such securities, except to the extent of its indirect pecuniary interest therein, if any."}],"balance_after":29105761,"source":{"system":"sec-edgar","filing":"0001209191-20-064259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919120064259/doc4.xml","form_type":"4"}},{"id":2939100,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":137986,"kind":"organization","name":"DCVC Bio, L.P.","position":1,"cik":"0001735069","reported_name":"DCVC Bio, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111559,"kind":"person","name":"Bogue Zachary","position":2,"cik":"0001836157","reported_name":"Bogue Zachary","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119945,"kind":"organization","name":"DCVC Bio GP, LLC","position":3,"cik":"0001735070","reported_name":"DCVC Bio GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137987,"kind":"organization","name":"JNK Capital Management, LLC","position":4,"cik":"0001836273","reported_name":"JNK Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75187,"kind":"person","name":"Ocko Matthew","position":5,"cik":"0001836089","reported_name":"Ocko Matthew","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137989,"kind":"person","name":"Stead Kiersten","position":6,"cik":"0001836117","reported_name":"Stead Kiersten","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137988,"kind":"organization","name":"ZNM Capital Management, LLC","position":7,"cik":"0001836103","reported_name":"ZNM Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2020-12-18T01:45:44.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":29076350,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A1 Preferred Shares and Series A2 Preferred Shares (collectively, the \"Preferred Shares\") were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering (\"IPO\"). The Preferred Shares converted into Common Shares at a 1:10 ratio upon the closing of the IPO without payment of additional consideration. The Preferred Shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held by DCVC Bio, L.P. (\"DCVC Bio\"). DCVC Bio GP, LLC (\"DCVC Bio GP\") is the general partner of DCVC Bio and has sole voting and dispositive power with regard to the securities held by DCVC Bio. JNK Capital Management, LLC (\"JNK\") and ZNM Capital Management, LLC (\"ZNM\") are the managing members of DCVC Bio GP and share voting and dispositive power with respect to the securities held by DCVC Bio. The managing members of JNK and ZNM are Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead. Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead share voting and dispositive power with respect to the securities held by DCVC Bio."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(Continued from Footnote 2) Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of such securities and this report shall not be deemed an admission that it is the beneficial owner of such securities, except to the extent of its indirect pecuniary interest therein, if any."}],"balance_after":29076350,"source":{"system":"sec-edgar","filing":"0001209191-20-064259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919120064259/doc4.xml","form_type":"4"}}]}